Ignite Creation Date:
2026-03-26 @ 3:14 PM
Ignite Modification Date:
2026-03-31 @ 5:52 AM
Study NCT ID:
NCT07432295
Status:
RECRUITING
Last Update Posted:
2026-02-25
First Post:
2026-02-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)
Sponsor:
I-Mab Biopharma US Limited
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-02
Start Date Type:
ESTIMATED
Primary Completion Date:
2030-03
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-08
Completion Date Type:
ESTIMATED
First Submit Date:
2026-02-11
First Submit QC Date:
None
Study First Post Date:
2026-02-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2026-02-18
Last Update Post Date:
2026-02-25
Last Update Post Date Type:
ACTUAL